The field of urologic oncology is experiencing rapid advancements in recent years, fueled by breakthroughs in diagnosis, treatment, and patient care. Innovative therapeutic modalities such as targeted therapy and immunotherapy are revolutionizing the landscape of urologic cancer care. Additionally, advancements in imaging techniques permit earlier